Trump Administration
Refine search
Pharmaceutical
A federal judge has put the brakes on changes to the USA’s childhood vaccine schedule made by Health and Human Services (HHS) Secretary Robert F Kennedy Jr (RFK Jr). 17 March 2026
Pharmaceutical
US pharma major AbbVie’s $100 billion agreement with the US administration signals a structural recalibration of drug pricing negotiations, tying tariff exemptions and pricing flexibility directly to domestic manufacturing expansion. 25 February 2026
Pharmaceutical
In a major ruling on Friday, the US Supreme Court struck down the bulk of President Donald Trump’s global tariff program, concluding that his administration lacked legal authority under the International Emergency Economic Powers Act (IEEPA) to impose broad import taxes without explicit congressional approval. 23 February 2026
Pharmaceutical
Delays in turning approved medicines into revenue, driven by pricing and reimbursement (P&R) processes, have emerged as one of the most critical challenges facing the pharmaceutical industry over the next year. 17 February 2026
Pharmaceutical
Having been pushed back from an expected January launch, the US government's TrumpRx website - intended to offer discounts on certain prescription drugs for cash-pay patients - made its debut late on Thursday. 6 February 2026
Pharmaceutical
The US Federal Trade Commission has hailed what it calls a ‘landmark settlement’ with one of the nation’s largest pharmacy benefit managers (PBMs), Express Scripts, and its affiliated entities. 5 February 2026
Pharmaceutical
The US Centers for Medicare & Medicaid Services (CMS) has announced the selection of 15 high-cost prescription medicines covered under Medicare Part D and—for the first time—those payable under Medicare Part B, for the third cycle of the Medicare Drug Price Negotiation Program. 28 January 2026
Pharmaceutical
The Centers for Medicare & Medicaid Services (CMS) is seeking public input on ways to strengthen domestic supply chains for personal protective equipment and essential medicines, as concerns persist over the USA’s heavy reliance on foreign manufacturing. 27 January 2026
Pharmaceutical
The USA has completed its withdrawal from the World Health Organization (WHO), according to a joint announcement by the US Department of Health and Human Services (HHS) and the US Department of State. The statement frames the move in overtly political terms, accusing the WHO of pandemic mismanagement and undue influence by member states. 23 January 2026
Pharmaceutical
Congressional negotiators released a more than 1,000 page bipartisan government funding bill on Tuesday, racing a shutdown deadline of 30 January and aiming to avoid another lapse after last fall’s lengthy shutd 21 January 2026
Biotechnology
French vaccine maker Valneva has abandoned its near-term US plans for its chikungunya vaccine Ixchiq, voluntarily withdrawing both its biologics license application and its investigational new drug filing after the American medicines regulator tightened the screws on safety. 20 January 2026
Pharmaceutical
The recent UK–US policy developments are reshaping global pharmaceutical investment and launch strategies, as governments on both sides of the Atlantic seek to secure supply, attract capital, and accelerate patient access, says intelligence and productivity platform GlobalData. 19 January 2026
Pharmaceutical
New data marks a major milestone in the nation’s fight against cancer: the five year relative survival rate for all cancers has reached 70% for people diagnosed between 2015 and 2021, according to the American Cancer Society. 19 January 2026
Pharmaceutical
President Donald Trump on Thursday unveiled what the White House calls the “Great Healthcare Plan,” an affordability-first package that he says would lower prescription drug prices and insurance premiums, while increasing transparency in the health system. 16 January 2026
Pharmaceutical
US President Donald Trump’s recent warning of a 25% tariff on countries trading with Iran introduces fresh uncertainty for India’s economic engagement with the West Asian nation. 14 January 2026
Pharmaceutical
US pharma major AbbVie has signed a voluntary agreement with the Trump administration that it says will lower prices in Medicaid while protecting its ability to invest in American drug innovation. 13 January 2026
Pharmaceutical
The inauguration of Japanese drug major Takeda's new, state-of-the-art filling line at its Neuchâtel, Switzerland, production site sends a powerful message, according to Dr René Buholzer, managing director of Swiss trade group InterPharma. 29 December 2025
Biotechnology
Neok Biotech’s $75 million series A venture round, which took the California-based biotech out of stealth mode, was not the largest fundraising event in November. However, it highlighted a rapidly growing investment trend: the rise of the NewCo. 24 December 2025
Pharmaceutical
Three more European big pharmas have announced plans join US President Trump's scheme to have the majority of medicines to be produced in the USA with the aim of reducing drug prices for Americans. 22 December 2025
Pharmaceutical
The US president has signed an Executive Order directing federal agencies to move more quickly toward rescheduling marijuana and expanding research into medical cannabis and cannabidiol products, a step welcomed by industry but unlikely to bring rapid legal change. 19 December 2025
Biosimilars
US lawmakers have introduced bipartisan legislation that would reduce routine reliance on comparative clinical efficacy studies in biosimilar approvals, a move welcomed by the Association for Accessible Medicines (AAM) and its Biosimilars Council. 16 July 2026
Biotechnology
The US Department of Health and Human Services has launched a department-wide clinical trials reform initiative aimed at accelerating drug development, reducing unnecessary regulatory burden and reinforcing the USA’s position in global biomedical research. 23 June 2026
Pharmaceutical
The US Trade Representative (USTR) has launched a Section 301 investigation into Germany’s pharmaceutical pricing policies, escalating a dispute over how the costs of innovative medicines are shared between the USA and other wealthy markets. 22 June 2026
Biotechnology
Chinese life sciences services group WuXi AppTec has sued the US government over its inclusion on a Pentagon list of companies alleged to have links to China’s military, escalating a dispute with potentially wide implications for pharma outsourcing. 22 June 2026
Pharmaceutical
Jeffery Taubenberger, the acting director of the US National Institute of Allergy and Infectious Diseases (NIAID), has stepped down from the role, according to reports citing congressional Democrats and sources familiar with the matter. 22 May 2026
Pharmaceutical
New US tariff measures and acute geopolitical tensions are reshaping the global pharmaceutical landscape, prompting companies to rethink supply chains and production strategies, says intelligence and productivity platform. GlobalData. 8 May 2026
Pharmaceutical
US President Donald Trump on April 18 issued an Executive Order directing the US Department of Health and Human Services to accelerate access to treatments for patients with serious mental illness, including devastating, complex, and treatment-resistant conditions. 25 April 2026
Pharmaceutical
US President Donald Trump has nominated Erica Schwartz to lead the Centers for Disease Control and Prevention (CDC) after a long search for a replacement for Susan Monarez, who was sacked in August last year. 17 April 2026
Pharmaceutical
The number of drug launches in Europe has fallen by around 35% in the 10 months since the USA introduced a new drug pricing policy, according to an analysis by the international research agency GlobalData. The figures are serious for European patients, says the Danish pharma trade group Lif. 13 April 2026
Pharmaceutical
Pharma trade group Medicines Australia says that, along with its members, it supports free, fair, and open trade and firmly oppose the proposed introduction of 100% tariffs on Australian branded and patented medicines exported to the USA. 10 April 2026
Pharmaceutical
Stephen Ubl will step down as president and chief executive of the Pharmaceutical Research and Manufacturers of America (PhRMA) at the end of 2026, ending a decade leading one of Washington’s most influential drug industry groups. 9 April 2026
Pharmaceutical
US Department of Health and Human Services (HHS) Secretary Robert F Kennedy Jr (RFK Jr) appears to have found a means of selecting members himself for a Centers for Disease Control and Prevention (CDC) vaccine advisory panel. 7 April 2026
Generics
In a dramatic move, the USA has announced a 100% tariff on all patented pharmaceutical imports, a decision aimed at bolstering domestic drug manufacturing and reducing reliance on foreign producers. 3 April 2026
Pharmaceutical
Nearly 8,000 clinical trial sites have been disrupted by the USA's escalating war on Iran, according to new analysis from clinical data firm Phesi, highlighting the fragility of globally distributed drug development. 2 April 2026
Pharmaceutical
US physician and biochemist Robert Malone has stepped down from the Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices, after a federal court ruling derailed a contentious revamp of the panel. 30 March 2026
Pharmaceutical
The USA remains the outlier among wealthy drug markets. OECD data for 2023 put US retail pharmaceutical spending at $1,713 per person, against an OECD average of $766. Germany was at $1,158 and Switzerland at $1,061. 30 March 2026
Pharmaceutical
Disruption in the Gulf has tightened oil flows through the Strait of Hormuz, a route that typically carries about a quarter of global seaborne crude. Before the Iran war, around 20 million barrels a day moved through the strait. A sustained reduction affects not just fuel markets, but the wider industrial system built around them. 24 March 2026
Pharmaceutical
The Irish economy has performed extraordinarily well recently despite its high vulnerability to rising US protectionism. 23 March 2026
Pharmaceutical
A group of Senate Democrats has set out an expansive healthcare reform agenda, targeting rising insurance costs and insurer profits while positioning the effort as a response to recent Republican-led policy changes. 20 March 2026
Pharmaceutical
The US administration’s TrumpRx initiative and a proposed Medicare incentive rule link drug pricing, tariff policy, and domestic manufacturing in a coordinated push to reshore pharmaceutical production, highlighting shifting industry priorities, says intelligence and productivity platform GlobalData. 17 March 2026
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2026
| Headless Content Management with Blaze